Congenital muscular dystrophy type 1B is a rare, genetic neuromuscular disorder characterized by proximal and symmetrical muscle weakness (particularly of neck, sternomastoid, facial and diaphragm mus...
Comprehensive, easy-to-understand information about this condition
How we create this content →The limited documentation surrounding congenital muscular dystrophy 1B reflects its extreme rarity, with a prevalence of less than 1 in 1,000,000. This rarity has hindered systematic clinical studies and comprehensive characterizations of the condition. As a result, many clinical features remain undocumented, and the understanding of the disease's progression is still evolving. However, ongoing research efforts may provide more insights in the future.
To navigate congenital muscular dystrophy 1B, consider consulting a neurologist with expertise in neuromuscular disorders. They can provide tailored advice and management strategies. Additionally, genetic counseling may be beneficial for understanding the inheritance pattern and implications for family members. While there are no identified patient organizations specifically for CMD1B, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Engaging in clinical trials could also be an option for accessing cutting-edge research and therapies.
Currently, there are 8 active clinical trials investigating various aspects of congenital muscular dystrophy 1B. These trials may explore potential therapies or management strategies for the condition. For more information on these trials, you can visit ClinicalTrials.gov and search for 'congenital muscular dystrophy 1B'. This research activity offers hope for better understanding and treatment options in the future.
Actionable guidance for navigating care for congenital muscular dystrophy 1B
To navigate congenital muscular dystrophy 1B, consider consulting a neurologist with expertise in neuromuscular disorders. They can provide tailored advice and management strategies. Additionally, genetic counseling may be beneficial for understanding the inheritance pattern and implications for family members. While there are no identified patient organizations specifically for CMD1B, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Engaging in clinical trials could also be an option for accessing cutting-edge research and therapies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding congenital muscular dystrophy 1B reflects its extreme rarity, with a prevalence of less than 1 in 1,000,000. This rarity has hindered systematic clinical studies and comprehensive characterizations of the condition. As a result, many clinical features remain undocumented, and the understanding of the disease's progression is still evolving. However, ongoing research efforts may provide more insights in the future.
To navigate congenital muscular dystrophy 1B, consider consulting a neurologist with expertise in neuromuscular disorders. They can provide tailored advice and management strategies. Additionally, genetic counseling may be beneficial for understanding the inheritance pattern and implications for family members. While there are no identified patient organizations specifically for CMD1B, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Engaging in clinical trials could also be an option for accessing cutting-edge research and therapies.
Currently, there are 8 active clinical trials investigating various aspects of congenital muscular dystrophy 1B. These trials may explore potential therapies or management strategies for the condition. For more information on these trials, you can visit ClinicalTrials.gov and search for 'congenital muscular dystrophy 1B'. This research activity offers hope for better understanding and treatment options in the future.
Actionable guidance for navigating care for congenital muscular dystrophy 1B
To navigate congenital muscular dystrophy 1B, consider consulting a neurologist with expertise in neuromuscular disorders. They can provide tailored advice and management strategies. Additionally, genetic counseling may be beneficial for understanding the inheritance pattern and implications for family members. While there are no identified patient organizations specifically for CMD1B, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Engaging in clinical trials could also be an option for accessing cutting-edge research and therapies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding congenital muscular dystrophy 1B reflects its extreme rarity, with a prevalence of less than 1 in 1,000,000. This rarity has hindered systematic clinical studies and comprehensive characterizations of the condition. As a result, many clinical features remain undocumented, and the understanding of the disease's progression is still evolving. However, ongoing research efforts may provide more insights in the future.
To navigate congenital muscular dystrophy 1B, consider consulting a neurologist with expertise in neuromuscular disorders. They can provide tailored advice and management strategies. Additionally, genetic counseling may be beneficial for understanding the inheritance pattern and implications for family members. While there are no identified patient organizations specifically for CMD1B, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Engaging in clinical trials could also be an option for accessing cutting-edge research and therapies.
Currently, there are 8 active clinical trials investigating various aspects of congenital muscular dystrophy 1B. These trials may explore potential therapies or management strategies for the condition. For more information on these trials, you can visit ClinicalTrials.gov and search for 'congenital muscular dystrophy 1B'. This research activity offers hope for better understanding and treatment options in the future.
Actionable guidance for navigating care for congenital muscular dystrophy 1B
To navigate congenital muscular dystrophy 1B, consider consulting a neurologist with expertise in neuromuscular disorders. They can provide tailored advice and management strategies. Additionally, genetic counseling may be beneficial for understanding the inheritance pattern and implications for family members. While there are no identified patient organizations specifically for CMD1B, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Engaging in clinical trials could also be an option for accessing cutting-edge research and therapies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Age of onset indicates when symptoms typically first appear.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.